Liver, and potential use in Breast & Lung Cancer treatment.
This market cap should be MUCH higher. I know it's had a good quarter, but the fact of the matter is CLSN should never have lived in the $2-$3 range.
Folks, Thermodox is smacking these tumors in a GOOD way. HEAT Trials/Data should show this. I think a # of Oncologists realize this is the FUTURE.
I'm absolutely floored that very little realize the potential here. This is not an efficient market IMO. Revenues could be 1-2B annually.
Do your DD ; Shorts are trying to stop this advance but I believe institutions will buy any dip. Don't get stopped. This stock is going much higher.
Sentiment: Strong Buy